Damien Luque Paz: Improving Myeloproliferative Neoplasm Diagnosis With Non Invasive Biomarkers
Damien Luque Paz, Professor of Hematology, University Hospital Physician at CHU d’Angers, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Leukemia, adding:
“I am very pleased to share our latest publication, now available online in Leukemia journal.
The aim was to evaluate whether a combination of non-invasive parameters could reliably distinguish essential thrombocythemia (ET), prefibrotic myelofibrosis (preMF), and overt primary myelofibrosis (PMF)
In this prospective study, we recruited newly diagnosed MPN patients in Angers and Brest Hospitals (128 patients, included in the BCB FIMBANK). We combined several non-invasive parameters: NGS sequencing, circulating CD34+ cell quantification, spleen elastography, and plasma levels of 29 cytokines and every bone marrow biopsy was centrally reviewed by three expert hematopathologists, with an independent adjudication committee integrating histology and clinicobiological data for final diagnosis classification.
The key findings are:
- The mutational landscape becomes progressively more complex from ET to preMF to PMF, with rising driver mutation allele burden
- On plasma cytokines: a distinct inflammatory profile and matrix-remodeling markers clearly set PMF apart from the other two entities.
- A two-step classification strategy (Lasso regression) combining clinical, genomic, and cytokine data identifies PMF very well (AUC 0.909), but showed more modest performance for distinguishing ET from preMF (AUC 0.762); a result consistent with the hypothesis of a pathophysiological continuum between these entities.
This work paves the way for non-invasive scores in MPNs, similar to those already used in hepatology for liver fibrosis
This study was made possible through an internal research grant from Angers University Hospital (AO interne 2018).”
Title: Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis
Authors: Carole Mosnier, Marie-Christine Copin, Isabelle Quintin-Roué, Eric Lippert, Yunjiao Lu, Jérémie Riou, Simon Blanchard, Nathalie Mérillon, Bertille Pawlicki, Françoise Boyer, Joris Argentin, Léa Sureau, Anaïs Malinge, Julie Sevestre, Marine Demoy, Christophe Aubé, Noémi Reboux, Jonathan Farhi, Aurélien Giltat, Christopher Nunes Gomes, Mathilde Hunault, Yves Delneste, Valérie Ugo, Jean-Christophe Ianotto, Corentin Orvain, Damien Luque Paz
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event